Colorectal cancer guidelines
Review and update of Clinical practice guidelines for the prevention, early detection and management of colorectal cancer
In 2022, Cancer Council Australia was contracted by the Australian Department of Health and Aged Care (the Department) to review and update selected chapters of the 2017 Clinical practice guidelines for the prevention, early detection and management of colorectal cancer (hereafter the Guidelines), namely the chapters titled: Population screening for colorectal cancer, and Risk and screening based on family history.
This review includes consideration of population health screening issues, the clinical and cost effectiveness of using iFOBTs as the principle screening mechanism, alternative screening techniques, evidence for maintaining or changing the existing 50-74 age cohort, and risk and screening strategies based on family history.
Public consultation feedback on the draft chapters of this guideline is now closed. Unfortunately, no late submissions will be accepted. For any questions, please contact [email protected], or [email protected].
Published: 2019
Status: This resource has been developed, reviewed or revised within the last five years.
The Australian Government Department of Health commissioned and funded Cancer Council Australia to undertake the current revision and update of this guideline.
The guideline recommendations were approved by the Chief Executive Officer of the National Health and Medical Research Council (NHMRC) on 7 December 2019 under section 14A of the National Health and Medical Research Council Act 1992. In approving the guideline recommendations, NHMRC is satisfied that the guideline recommendations are systematically derived, based on the identification and synthesis of the best available scientific evidence, and developed for health professionals practising in an Australian health care setting.
Published: 2017.
Status: This resource has been developed, reviewed or revised within the last five years.
The Australian Government Department of Health commissioned and funded Cancer Council Australia to undertake the current revision and update of this guideline.
The guideline recommendations were approved by the Chief Executive Officer of the National Health and Medical Research Council (NHMRC) on 27 October 2017 under section 14A of the National Health and Medical Research Council Act 1992. In approving the guideline recommendations, NHMRC is satisfied that the guideline recommendations are systematically derived, based on the identification and synthesis of the best available scientific evidence, and developed for health professionals practising in an Australian health care setting.
Browse all Clinical Practice Guidelines